
Christopher T Ritchlin MD
Rheumatoid Arthritis & Related, Vasculitis
Professor, Medicine, University of Rochester School of Medicine & Dentistry
Join to View Full Profile
400 Red Creek DrSuite 240Rochester, NY 14623
Phone+1 585-486-0901
Fax+1 585-340-5399
Dr. Ritchlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- NYU Grossman School of MedicineFellowship, Rheumatology, 1986 - 1989
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1983 - 1985
- Albany Medical CenterInternship, Internal Medicine, 1982 - 1983
- Albany Medical CollegeClass of 1982
Certifications & Licensure
- NY State Medical License 1984 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Centocor Microarray Study of Patients Start of enrollment: 2007 Mar 01
- Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy Start of enrollment: 2009 Jul 01
- Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA) Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial.Iain B McInnes, Laura C Coates, Philip J Mease, Alexis Ogdie, Arthur Kavanaugh
Nature Medicine. 2025-10-06 - Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study.Christopher T Ritchlin, Ennio Lubrano, Maria Sole Chimenti, Evan Leibowitz, Mohamed Sharaf
Rheumatology and Therapy. 2025-10-01 - Relationship of radiographic progression status to low disease activity in patients with psoriatic arthritis receiving secukinumab treatment for two years.Philip J Mease, Laura C Coates, Corine Gaillez, Alexis Shew, Weibin Bao
Rheumatology. 2025-09-18
Journal Articles
- Psoriasis: Psychosomatic, Somatopsychic, or Both?Chase W Kwon, Francisco Tausk, Christopher Ritchlin, ScienceDirect
Press Mentions
- Rethinking Fibromyalgia: Nociplastic Pain’s Big ImpactFebruary 19th, 2025
- New Ideas on PsA Pathogenesis May Drive New TreatmentsJanuary 7th, 2025
- Meet the Professor: Axial SpondyloarthritisOctober 14th, 2024
- Join now to see all
Grant Support
- ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and SynoviumUNIVERSITY OF ROCHESTER2022–2026
- ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and SynoviumUNIVERSITY OF ROCHESTER2022–2026
- Role Of B Cells In Synovial Inflammation &Ln Remodeling In RA ArthritisNational Institute Of Allergy And Infectious Diseases2010–2011
- Osteoclastic Bone Resorption In Psoriatic ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2003
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: